We are live on ! Find out more
BFRIW icon

Biofrontera

5 hedge funds and large institutions have $4.48K invested in Biofrontera in 2026 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.07% less ownership

Funds ownership: 14.22%11.15% (-3.1%)

17% less funds holding

Funds holding: 65 (-1)

45% less capital invested

Capital invested by funds: $8.21K → $4.48K (-$3.73K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.83K
Name Holding Trade Value Shares
Change
Change in
Stake
BA
1
Bard Associates
Illinois
$4.17K
CS
2
Clear Street
New York
$243
Osaic Holdings
3
Osaic Holdings
Arizona
$33
US Bancorp
4
US Bancorp
Minnesota
$27
UBS Group
5
UBS Group
Switzerland
$9 -1 -0.3%
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
-$1.83K -45,804 Closed

BFRIW Hedge Fund Activity: Q2 2026 in Review

5 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q2 2026, worth a combined $4.48K — down 45% from $8.21K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BFRIW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.83K sold.

  • 5 institutional investors held Biofrontera (BFRIW) as of Q2 2026, down from 6 in Q1 2026.
  • Funds reported $4.48K of Biofrontera stock for Q2 2026, down 45% quarter-over-quarter.
  • 0 funds opened new Biofrontera positions in Q2 2026 and 1 closed out, a net change of -1 holder.
  • The largest Biofrontera seller in Q2 2026 was Susquehanna International Group, an estimated $1.83K sold.

Based on aggregated 13F filings for Q2 2026.